Share repurchase programme: Transactions of week 32 2026
The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”).
The following transactions have been made under the program:
| Number of shares | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, previous announcement | 1,642,524 | 921.98 | 1,514,372,113 |
| 3 August 2026 | 11,422 | 1.032.31 | 11,791,020 |
| 4 August 2026 | 11,309 | 1.042.57 | 11,790,470 |
| 5 August 2026 | 11,307 | 1.043.37 | 11,797,411 |
| 6 August 2026 | 10,374 | 1.058.42 | 10,980,037 |
| 7 August 2026 | 11,349 | 1.039.17 | 11,793,516 |
| Accumulated under the programme | 1,698,285 | 925.95 | 1,572,524,567 |
Following settlement of the transactions stated above, Jyske Bank will own a total of 1,698,285 of treasury shares, excluding investments made on behalf of customers and shares held for trading purposes, corresponding to 2.92% of the share capital.
Attached to this corporate announcement, aggregated details on the transactions related to the share repurchase programme are shown by venue.
Yours faithfully,
Jyske Bank
Contact: Birger Krøgh Nielsen, CFO, tel. +45 25 26 92 42.
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Form 8.5 (EPT/RI) - Pharos Energy Plc
- Net Asset Value
- Internationally Recognized Johns Hopkins Oncologist Dr. Stephen J. Noga Joins Immunocine as Chief Medical Officer
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stock Buyback, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share